Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Aarden

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2021
Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentationFrank Dahlke, Douglas L Arnold, Piet Aarden, et al.
Brain : a Journal of Neurology|February 1, 2022
How patients with multiple sclerosis acquire disabilityFred D Lublin, Dieter A Häring, Habib Ganjgahi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2024
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate modelAlex Ocampo, Farhad Hatami, Jelena Čuklina, et al.
Nature Medicine|August 20, 2025
AI-driven reclassification of multiple sclerosis progressionHabib Ganjgahi, Dieter A Häring, Piet Aarden, et al.
BMC Medical Research Methodology|November 14, 2021
Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysisAnn-Marie Mallon, Dieter A Häring, Frank Dahlke, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2021
Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentationFrank Dahlke, Douglas L Arnold, Piet Aarden, et al.
Brain : a Journal of Neurology|February 1, 2022
How patients with multiple sclerosis acquire disabilityFred D Lublin, Dieter A Häring, Habib Ganjgahi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2024
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate modelAlex Ocampo, Farhad Hatami, Jelena Čuklina, et al.
Nature Medicine|August 20, 2025
AI-driven reclassification of multiple sclerosis progressionHabib Ganjgahi, Dieter A Häring, Piet Aarden, et al.
BMC Medical Research Methodology|November 14, 2021
Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysisAnn-Marie Mallon, Dieter A Häring, Frank Dahlke, et al.
Pageof 1